⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30019312 | 1.00 | — | — | |
| SCHEMBL29670201 | 0.78 | — | — | |
| SCHEMBL487841 | 0.78 | — | — | |
| SCHEMBL940010 | 0.78 | — | — | |
| SCHEMBL29561566 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL6588208 | 0.76 | NOS3 (0.37) | — | |
| SCHEMBL24742242 | 0.74 | — | — | |
| SCHEMBL250736 | 0.74 | — | — | |
| SCHEMBL4022308 | 0.74 | — | — | |
| SCHEMBL21856101 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4705298-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | Moma Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12559508-B2 | Semi-saturated bicyclic derivatives and related uses | MOMA THERAPEUTICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250230171-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20250049772-A1 | PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-02-13 | — | — | US | disclosed |
| US-12195482-B1 | Compounds as inhibitors of AXL | ARCUS BIOSCIENCES, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240425526-A1 | COMPOUNDS AS INHIBITORS OF AXL | ARCUS BIOSCIENCES, INC. (US) | 2024-12-26 | — | — | US | disclosed |
| WO-2024211836-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| EP-4217062-B1 | CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-10-09 | — | — | EP | disclosed |
| US-12037323-B2 | Uracil derivatives as Mer-AXL inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2006065204-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| WO-2006065204-A1 | SUBSTITUTED AMINOPYRIDINES AND USES THEREOF | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| CN-1152021-C | Corticotropin release factors antagonistic agent | ������ҩ������˾ | 2004-06-02 | — | — | CN | disclosed |
| CN-1082949-C | Process for converting 2, 4-dichloropyridines into 2-aryloxy-4-chloropyridines | PFIZER (US) | 2002-04-17 | — | — | CN | disclosed |
| CN-1246475-A | Corticotropin release factors antagonistic agent | PFIZER (US) | 2000-03-08 | — | — | CN | disclosed |
| CN-1049659-C | Corticotropin releasing factor antagonists | PFIZER (US) | 2000-02-23 | — | — | CN | disclosed |
| CN-1186486-A | Process for converting 2, 4-dichloropyridines into 2-aryloxy-4-chloropyridines | PFIZER (US) | 1998-07-01 | — | — | CN | disclosed |
| CN-1150428-A | Corticotropin releasing factor antagonists | PFIZER (US) | 1997-05-21 | — | — | CN | disclosed |
| US-4898608-A | Pyridylthio-acylanilide herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1990-02-06 | — | — | US | disclosed |
| EP-0243868-A2 | Pyridylthio-acylanilides | BAYER AG (DE) | 1987-11-04 | — | — | EP | disclosed |